Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to ...

Diabetes drugs may be doing more than managing blood sugar, they could also shape cancer biology in unexpected ways.

Researchers discovered a promising leukemia drug breakthrough that could help patients overcome treatment resistance, ...

Common diabetes drugs may do more than regulate blood sugar—they could also influence how cancers grow, spread, or slow down.

Additionally, in 2025, the U.S. Food and Drug Administration (FDA) approved 11 drugs based on clinical trials in which MSK played a pivotal role. “MSK’s clinical research teams made great progress in ...

A recent review examined how widely used treatments such as metformin, SGLT2 inhibitors, and GLP-1 receptor agonists may ...

Precision oncology advancements have led to new treatment options for gastric cancer, including immunotherapy and targeted ...

A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors ...

Datopotamab deruxtecan received FDA approval for HR+/HER2– breast cancer, improving progression-free survival and overall ...

Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries at risk of ineffective treatments and potentially fatal side effects, an ...

Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical ...